• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[对巴西里约热内卢州里约热内卢市“克莱门蒂诺·弗拉加·菲略”大学医院炎症性肠病住院患者的社会、临床、实验室和人体测量学特征的描述性分析]

[Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the "Clementino Fraga Filho" University Hospital, Rio de Janeiro, RJ, Brazil].

作者信息

Elia Paula Peruzzi, Fogaça Homero Soares, Barros Rodrigo G G Rego, Zaltman Cyrla, Elia Celeste Siqueira C

机构信息

Serviço de Endoscopia Digestiva Pediátrica, Departamento de Cirurgia Pediátrica, Instituto Fernandes Figueira, Fiocruz, Brazil.

出版信息

Arq Gastroenterol. 2007 Oct-Dec;44(4):332-9. doi: 10.1590/s0004-28032007000400010.

DOI:10.1590/s0004-28032007000400010
PMID:18317653
Abstract

BACKGROUND

The epidemiologic survey in Brazil is limited probably due to a diagnosis deficiency and a small number of population-based studies performed. The majority of the prevalence studies available have evaluated inflammatory bowel diseases outpatients, but the knowledge of the profile of inflammatory bowel diseases inpatients is important in order to detect predictive markers of disease severity that will allow earlier medical intervention decreasing the rate of hospitalization and reducing the Health System costs.

AIM

To determine social, clinical, laboratorial and anthropometric profiles of hospitalized adults inflammatory bowel diseases patients of a tertiary university hospital.

METHODS

Prospective study was performed with 43 inflammatory bowel diseases inpatients from clinical and surgical wards and emergency section of university hospital. We characterized demographic data, presence of comorbidities, disease location and behavior, surgical past-history, extra intestinal manifestations using standardized definitions. Laboratory results were abstracted from medical records and anthropometric measures were performed during our visit.

RESULTS

The vast majority of the inflammatory bowel diseases patients had Crohn's disease (72.1%), with ileocolic involvement (60%), with a penetrating disease behavior (77.4%) while ulcerative colitis group presented mostly pancolitis (50%). Articular pain was the most common (44.2%) extra intestinal manifestation of inflammatory bowel diseases patients and 97.7% of them had at least one type of complication related to disease. Although, the previous use of specific medical therapies to inflammatory bowel diseases before the hospitalization (more frequently corticosteroids) was done (79%), the majority of the patients were hospitalized because of inflammatory bowel diseases activity. Disease activity was present in 80.7% of Crohn's disease and 50% ulcerative colitis patients. Inflammatory bowel diseases mortality rate was 5.5% (2/36). Comorbidities presence occurred only in 30.2% of inflammatory bowel diseases patients. The predominant surgery performed was intestinal resection. The interval between the symptoms appearance and the definitive diagnosis was less than 1 year in more than 70% of inflammatory bowel diseases patients. Laboratory findings detected were a decreased serum albumin (85.7%) and anemia (69.8%). The majority of the patients had at least one anthropometric alteration. The social stratification of the inflammatory bowel diseases group was similar to the Brazilian population.

CONCLUSION

The inflammatory bowel diseases inpatients from the university hospital wards had more severe evolution of these illnesses with an active and extensive disease with complications and frequent extra intestinal manifestations, despite the prolonged use of corticosteroids. The higher prevalence of Crohn's disease inpatients than ulcerative colitis could reflect a higher aggressive behavior of this disease. The reduced serum albumin, anemia and anthropometric alterations are common inflammatory bowel diseases inpatients and could be related to a major severity of inflammatory bowel diseases evolution.

摘要

背景

巴西的流行病学调查可能受到限制,这可能是由于诊断不足以及基于人群的研究开展较少。现有的大多数患病率研究评估的是炎症性肠病门诊患者,但了解炎症性肠病住院患者的特征对于发现疾病严重程度的预测标志物很重要,这将有助于早期医疗干预,降低住院率并减少卫生系统成本。

目的

确定一所三级大学医院中住院的成年炎症性肠病患者的社会、临床、实验室和人体测量学特征。

方法

对来自大学医院临床、外科病房及急诊科的43例炎症性肠病住院患者进行前瞻性研究。我们使用标准化定义对人口统计学数据、合并症的存在情况、疾病部位和行为、手术史、肠外表现进行了特征描述。实验室结果从病历中提取,人体测量在我们访视期间进行。

结果

绝大多数炎症性肠病患者患有克罗恩病(72.1%),病变累及回结肠(60%),疾病行为为穿透性(77.4%),而溃疡性结肠炎组大多为全结肠炎(50%)。关节疼痛是炎症性肠病患者最常见的肠外表现(44.2%),其中97.7%的患者至少有一种与疾病相关的并发症。尽管在住院前曾使用过针对炎症性肠病的特定药物治疗(最常用的是皮质类固醇)(79%),但大多数患者因炎症性肠病活动而住院。80.7%的克罗恩病患者和50%的溃疡性结肠炎患者存在疾病活动。炎症性肠病死亡率为5.5%(2/36)。仅30.2%的炎症性肠病患者存在合并症。主要进行的手术是肠切除术。超过70%的炎症性肠病患者症状出现至明确诊断的间隔时间少于1年。检测到的实验室结果包括血清白蛋白降低(85.7%)和贫血(69.8%)。大多数患者至少有一种人体测量学改变。炎症性肠病组的社会分层与巴西人群相似。

结论

尽管长期使用皮质类固醇,但大学医院病房的炎症性肠病住院患者病情进展更为严重,疾病活跃且广泛,伴有并发症和频繁的肠外表现。克罗恩病住院患者的患病率高于溃疡性结肠炎,这可能反映了该疾病更具侵袭性的行为。血清白蛋白降低、贫血和人体测量学改变在炎症性肠病住院患者中很常见,可能与炎症性肠病进展的更严重程度有关。

相似文献

1
[Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the "Clementino Fraga Filho" University Hospital, Rio de Janeiro, RJ, Brazil].[对巴西里约热内卢州里约热内卢市“克莱门蒂诺·弗拉加·菲略”大学医院炎症性肠病住院患者的社会、临床、实验室和人体测量学特征的描述性分析]
Arq Gastroenterol. 2007 Oct-Dec;44(4):332-9. doi: 10.1590/s0004-28032007000400010.
2
[Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil].[巴西东南部一所大学医院克罗恩病和溃疡性结肠炎的发病趋势(1980 - 1999年)及临床特征]
Arq Gastroenterol. 2002 Apr-Jun;39(2):98-105. doi: 10.1590/s0004-28032002000200006. Epub 2003 Feb 19.
3
INFLAMMATORY BOWEL DISEASE: OUTPATIENT TREATMENT PROFILE.炎症性肠病:门诊治疗概况。
Arq Gastroenterol. 2017 Apr-Jun;54(2):96-100. doi: 10.1590/S0004-2803.201700000-01. Epub 2017 Mar 16.
4
Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.炎症性肠病中的贫血:患病率、鉴别诊断及其与临床和实验室指标的关联
Sao Paulo Med J. 2014;132(3):140-6. doi: 10.1590/1516-3180.2014.1323568. Epub 2014 Apr 14.
5
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.加拿大一所三级护理大学医院中炎症性肠病患者的直接住院费用。
Am J Gastroenterol. 2000 Mar;95(3):677-83. doi: 10.1111/j.1572-0241.2000.01845.x.
6
THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.炎症性肠病患者临床症状的发作
Arq Gastroenterol. 2018 Jul-Sep;55(3):290-295. doi: 10.1590/S0004-2803.201800000-73.
7
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.克罗恩病和溃疡性结肠炎的肠外并发症:一项对700例患者的研究
Medicine (Baltimore). 1976 Sep;55(5):401-12. doi: 10.1097/00005792-197609000-00004.
8
Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.土耳其炎症性肠病患者贫血的频率、类型和治疗方法。
World J Gastroenterol. 2018 Sep 28;24(36):4186-4196. doi: 10.3748/wjg.v24.i36.4186.
9
Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study.韩国炎症性肠病患者的总体死亡率和特定病因死亡率:一项基于医院的队列研究。
J Gastroenterol Hepatol. 2017 Apr;32(4):782-788. doi: 10.1111/jgh.13596.
10
Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).α干扰素(IFNα2a)治疗疱疹病毒相关性炎症性肠病(溃疡性结肠炎和克罗恩病)。
Hepatogastroenterology. 1998 May-Jun;45(21):691-9.

引用本文的文献

1
Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.墨西哥溃疡性结肠炎患者的关节受累:一项基于医院的回顾性研究。
Clin Rheumatol. 2018 Mar;37(3):677-682. doi: 10.1007/s10067-017-3834-z. Epub 2017 Sep 15.
2
Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients.炎症性肠病患者的临床和社会人口学特征
Gastroenterology Res. 2015 Aug;8(3-4):207-215. doi: 10.14740/gr649w. Epub 2015 Jul 22.
3
Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
巴西东北部一个欠发达地区的炎症性肠病
World J Gastroenterol. 2015 Jan 28;21(4):1197-206. doi: 10.3748/wjg.v21.i4.1197.